These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11912816)

  • 1. Implications of the United Kingdom Prospective Diabetes Study (UKPDS) results on patient management.
    Nicollerat JA
    Diabetes Educ; 2000; 26 Suppl():8-10. PubMed ID: 11912816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of diabetes mellitus in older persons.
    Zarowitz BJ
    Geriatr Nurs; 2006; 27(2):77-82. PubMed ID: 16638476
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group.
    UK Prospective Diabetes Study Group
    BMJ; 1998 Sep; 317(7160):713-20. PubMed ID: 9732338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of the United Kingdom prospective diabetes study.
    Baldeweg SE; Yudkin JS
    Prim Care; 1999 Dec; 26(4):809-27. PubMed ID: 10523461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies.
    Meier M; Hummel M
    Vasc Health Risk Manag; 2009; 5():859-71. PubMed ID: 19898642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glycemic regulation and management of essential hypertension in diabetics with type 2 diabetes mellitus; the 'United Kingdom prospective diabetes study' of diabetic complications].
    Wolffenbuttel BH; Heine RJ
    Ned Tijdschr Geneeskd; 1999 Jun; 143(23):1197-201. PubMed ID: 10389533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes.
    CDC Diabetes Cost-effectiveness Group
    JAMA; 2002 May; 287(19):2542-51. PubMed ID: 12020335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.
    Bakris GL; Fonseca V; Katholi RE; McGill JB; Messerli FH; Phillips RA; Raskin P; Wright JT; Oakes R; Lukas MA; Anderson KM; Bell DS;
    JAMA; 2004 Nov; 292(18):2227-36. PubMed ID: 15536109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glycemic targets and cardiovascular morbi-mortality].
    Bordier L; Bauduceau B
    Presse Med; 2013 May; 42(5):855-60. PubMed ID: 23286961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up of intensive glucose control in type 2 diabetes.
    Cruickshank JM
    N Engl J Med; 2009 Jan; 360(4):417-8; author reply 418. PubMed ID: 19172673
    [No Abstract]   [Full Text] [Related]  

  • 11. [The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes].
    Gaede PH; Jepsen PV; Larsen JN; Jensen GV; Parving HH; Pedersen OB
    Ugeskr Laeger; 2003 Jun; 165(26):2658-61. PubMed ID: 12886549
    [No Abstract]   [Full Text] [Related]  

  • 12. Managing cardiovascular risk in patients with diabetes.
    Rydén L
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i23-5:discussion i50. PubMed ID: 10956316
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group.
    UK Prospective Diabetes Study Group
    BMJ; 1998 Sep; 317(7160):720-6. PubMed ID: 9732339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antihypertensive treatment in the type 2 diabetic].
    Fournier A
    Nephrologie; 2000; 21(4):203-4. PubMed ID: 10976435
    [No Abstract]   [Full Text] [Related]  

  • 15. An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54).
    Gray A; Clarke P; Raikou M; Adler A; Stevens R; Neil A; Cull C; Stratton I; Holman R;
    Diabet Med; 2001 Jun; 18(6):438-44. PubMed ID: 11472461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of hypertension in patients with diabetes.
    Smith A
    Nurs Clin North Am; 2001 Jun; 36(2):273-89, vii. PubMed ID: 11382563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycaemic and blood pressure controls achieved in a cohort of 318 patients with type 2 diabetes.
    Buysschaert M; Hermans MP
    Acta Clin Belg; 1999 Dec; 54(6):328-33. PubMed ID: 10686705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renin-angiotensin system blockade reduces cardiovascular mortality and morbidity attributable to arterial hypertension by primary and secondary prevention. The end of the road?].
    Coca A; Ruilope LM
    Med Clin (Barc); 2000 Jul; 115(5):178-80. PubMed ID: 10996874
    [No Abstract]   [Full Text] [Related]  

  • 19. A review of the United Kingdom Prospective Diabetes Study (UKPDS) and a discussion of the implications for patient care.
    Srimanunthiphol J; Beddow R; Arakaki R
    Hawaii Med J; 2000 Jul; 59(7):295-8, 313. PubMed ID: 10961040
    [No Abstract]   [Full Text] [Related]  

  • 20. Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials.
    Reboldi G; Gentile G; Angeli F; Verdecchia P
    Vasc Health Risk Manag; 2009; 5(1):411-27. PubMed ID: 19475778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.